首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1800305

採血管市場：未來預測（2025-2030）

Blood Collection Tubes Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計採血管市場規模將從 2025 年的 35.03 億美元成長至 2030 年的 46.33 億美元，複合年成長率為 5.75%。

由於慢性病盛行率上升、人口老化以及外科手術增多，全球採血管市場可望顯著成長。血液檢測和儲存需求日益成長，尤其是對於糖尿病和癌症等需要頻繁診斷的疾病，推動了該市場的蓬勃發展。採血管設計技術的進步，包括效率的提高和易用性的提升，進一步推動了需求的成長。儘管面臨製造成本高昂和法規複雜等挑戰，但強大的醫療基礎設施仍為該市場提供了支撐，其中美國憑藉其先進的醫療生態系統和高檢測量，正在成為市場主導。

市場促進因素

糖尿病和癌症等慢性疾病的日益流行，是頻繁進行血液檢測以進行診斷和監測的主要促進因素。世界衛生組織 (WHO) 報告稱，全球共有 1,020 萬例結核病病例，其中包括 120 萬名兒童，這凸顯了對可靠採血系統的需求。外科手術數量的增加也推動了市場成長，使得採血管對於術前和術後檢測至關重要。例如，葡萄牙、丹麥、挪威和愛爾蘭等歐洲國家的外科手術量很高，凸顯了對高效採血解決方案的需求。此外，血清分離技術的進步，例如 BD 於 2023 年 1 月推出的含 K2EDTA 的 Vacutainer® 血清管，提高了可用性並支持外科手術，進一步推動了市場擴張。 WHO 2023 年 6 月的資料顯示，共採集了 1.185 億個採血管。全球捐血的增加進一步擴大了對專用採血管的需求，以確保血液的安全儲存和檢測。

介紹
北美洲
- 依產品類型
- 依材料類型
- 按最終用戶
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 依產品類型
- 依材料類型
- 按最終用戶
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 依產品類型
- 依材料類型
- 按最終用戶
- 按國家
  - 英國
  - 德國
  - 法國
  - 西班牙
  - 其他
中東和非洲
- 依產品類型
- 依材料類型
- 按最終用戶
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 以色列
  - 其他
亞太地區
- 依產品類型
- 依材料類型
- 按最終用戶
- 按國家
  - 日本
  - 中國
  - 印度
  - 韓國
  - 印尼
  - 台灣
  - 其他

第9章競爭格局及分析

主要企業和策略分析
新興企業和市場盈利
企業合併、協議、商業合作
供應商競爭力矩陣

第10章：公司簡介

BD
Cardinal Health
CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
FL MEDICAL Srl
Fresenius Kabi AG
Greiner Bio One International GmbH
Thermo Fisher Scientific Inc.
Kawasumi Laboratories America
McKesson Medical-Surgical Inc.
QIAGEN
SARSTEDT AG & Co. KG
AdvaCare Pharma

簡介目錄

Product Code: KSI061613462

The Blood Collection Tubes Market is expected to grow from USD 3.503 billion in 2025 to USD 4.633 billion in 2030, at a CAGR of 5.75%.

The global blood collection tubes market is poised for significant growth, driven by the rising prevalence of chronic diseases, an aging population, and increasing surgical procedures. The market is fueled by the growing need for blood testing and storage, particularly for conditions like diabetes and cancer, which require frequent diagnostics. Technological advancements in tube design, such as improved efficiency and user-friendliness, further propel demand. Despite challenges like high production costs and regulatory complexities, the market is supported by robust healthcare infrastructure, with the United States emerging as a dominant market due to its advanced medical ecosystem and high testing volumes.

Market Drivers

The increasing incidence of chronic diseases, such as diabetes and cancer, is a primary driver, necessitating frequent blood tests for diagnosis and monitoring. The World Health Organization reported 10.2 million tuberculosis cases globally, including 1.2 million children, highlighting the demand for reliable blood collection systems. The growing number of surgical procedures also boosts market growth, as blood collection tubes are essential for preoperative and postoperative testing. For instance, high surgical volumes in European countries like Portugal, Denmark, Norway, and Ireland underscore the need for efficient blood collection solutions. Additionally, technological advancements, such as BD's Vacutainer(R) Serum Tube with K2EDTA launched in January 2023 for serum separation, enhance usability and support surgical applications, driving market expansion. The global rise in blood donations, with 118.5 million units collected as per WHO's June 2023 data, further amplifies demand for specialized tubes to ensure safe storage and testing.

Market Segmentation

The market is segmented by application, tube type, and geography. Applications include diagnostics, surgical procedures, and blood donation, with diagnostics leading due to chronic disease prevalence. Tube types encompass serum, plasma, and EDTA tubes, tailored to specific testing needs. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The United States dominates North America, driven by its USD 3.8 trillion healthcare industry in 2022 and high surgical and diagnostic activity. The integration of microfluidics in point-of-care (POC) diagnostics, enabling portable and affordable testing, further supports market growth in the region.

Industry Analysis

Porter's Five Forces model evaluates competitive dynamics, analyzing supplier power, buyer influence, and market rivalry. An industry value chain analysis identifies key players in tube manufacturing, distribution, and healthcare integration, emphasizing their roles in ensuring quality and efficiency. The regulatory framework, including standards for medical device safety and quality, is critical for maintaining trust and compliance, particularly in high-income countries with stringent healthcare regulations.

Competitive Landscape

Key players, such as BD, focus on innovation, developing advanced tubes like the Vacutainer(R) series to meet surgical and diagnostic needs. The vendor matrix categorizes companies as leaders, followers, challengers, or niche players based on their strategies, with an emphasis on user-friendly and efficient solutions. Investments in R&D and partnerships with healthcare providers strengthen market positions.

Challenges

High production costs for advanced blood collection tubes and stringent regulatory requirements pose barriers. Ensuring consistent quality across diverse applications and addressing supply chain constraints in developing regions are additional challenges requiring strategic solutions.

The blood collection tubes market is set for robust growth, driven by chronic disease prevalence, surgical demand, and technological advancements. The U.S. leads due to its advanced healthcare infrastructure and high testing volumes, while Asia Pacific shows potential with rising healthcare needs. Continued innovation and regulatory compliance will be critical for overcoming cost and quality challenges, ensuring the market meets global diagnostic and surgical demands.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

EDTA Tubes
Heparin Tube
Heparin Plasma Separating Tube
Serum Separating Tube
Others

By Material Type

Plastic
Polyethylene Terephthalate
Polypropylene
Polystyrene
Others
Glass

By End-User

Diagnostics Centers
Hospitals and Clinics
R&D Centers

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Data
2.3. Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY PRODUCT TYPE

5.1. Introduction
5.2. EDTA Tubes
5.3. Heparin Tube
5.4. Heparin Plasma Separating Tube
5.5. Serum Separating Tube
5.6. Others

6. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY MATERIAL TYPE

6.1. Introduction
6.2. Plastic
- 6.2.1. Polyethylene Terephthalate
- 6.2.2. Polypropylene
- 6.2.3. Polystyrene
- 6.2.4. Others
6.3. Glass

7. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY END-USER

7.1. Introduction
7.2. Diagnostics Centers
7.3. Hospitals and Clinics
7.4. R&D Centers

8. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Product Type
- 8.2.2. By Material Type
- 8.2.3. By End-Users
- 8.2.4. By Country
  - 8.2.4.1. United States
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Product Type
- 8.3.2. By Material Type
- 8.3.3. By End-Users
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Product Type
- 8.4.2. By Material Type
- 8.4.3. By End-Users
- 8.4.4. By Country
  - 8.4.4.1. UK
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Product Type
- 8.5.2. By Material Type
- 8.5.3. By End-Users
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. United Arab Emirates
  - 8.5.4.3. Israel
  - 8.5.4.4. Others
8.6. Asia Pacific
- 8.6.1. By Product Type
- 8.6.2. By Material Type
- 8.6.3. By End-Users
- 8.6.4. By Country
  - 8.6.4.1. Japan
  - 8.6.4.2. China
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Indonesia
  - 8.6.4.6. Taiwan
  - 8.6.4.7. Others